Novo Nordisk partners with Anthropic to speed AI-driven drug discovery

TL;DR Summary
Danish pharma company Novo Nordisk is teaming up with Anthropic to use Claude and Claude Science to accelerate medicine research and AI-powered software, aiming to become the world’s most AI-driven healthcare company with robust data governance and human oversight as it seeks to shorten timelines for medical breakthroughs.
- Ozempic-maker turns to Anthropic to turbocharge medical research politico.eu
- Novo Partners With Anthropic to Speed Up Drug Discovery Using Claude WSJ
- Novo Will Work With Anthropic AI to Speed Drug Development Bloomberg.com
- Novo, Anthropic sign deal to apply AI to drug discovery Endpoints News
- Novo partners with Anthropic to speed up drug development with Claude Reuters
Reading Insights
Total Reads
0
Unique Readers
5
Time Saved
3 min
vs 3 min read
Condensed
92%
570 → 48 words
Want the full story? Read the original article
Read on politico.eu